Biomarker NTRK Coverage from Every Angle

Gregory J. Riely, MD, PhD, on Identifying Patients With NTRK Fusions

Posted: Wednesday, September 1, 2021

Gregory J. Riely, MD, PhD, of Memorial Sloan Kettering Cancer Center, discusses some of the key issues in identifying patients whose tumors harbor NTRK fusions, including the types of tests to perform, the types of disease that should be tested, as well as the need for broad testing.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.